Virus Filtration Market is segmented By Product (Consumables, Instruments, Services, Others), By Application (Biological, Medical Devices, Water Purification, Air Purification, Other), By End-User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic Research Institutes, Other) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031
Report Overview
Global Virus Filtration Market reached US$ 4.71 billion in 2023 and is expected to reach US$ 11.51 billion by 2031, growing at a CAGR of 12.2 % during the forecast period 2024-2031.
The virus filtration phase must be validated using simulated worst-case processing conditions to meet regulatory requirements. Virus filtration is one of the primary unit activities used to ensure the viral safety of biopharmaceutical processes by employing a strong size-exclusion mechanism.
Virus filtration is an effective method for ensuring virus safety during biotherapeutic manufacturing procedures. This procedure separates viruses based on size and is an important component of viral safety assurance in downstream processing.
Market Scope
Metrics | Details |
CAGR | 12.2% |
Market Size Available for Years | 2022-2031 |
Estimation Forecast Period | 2024-2031 |
Revenue Units | Value (US$ Mn) |
Segments Covered | Product, Application, End-User |
Regions Covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
Largest Region | North America |
Fastest Growing Region | Asia-Pacific |
Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For more details on this report - Request for Sample
Market Dynamics: Drivers & Restraints
Increasing research and development
The increasing research and developmental activities are expected to drive the market. Pharmaceutical, biotechnology and biopharmaceutical companies are increasingly researching to innovate new biologics or drugs and other products. Virus filtration has been an important step in these procedures.
With the rising research and development, there is an increasing demand for virus filtration systems and kits and reagents. For instance, according to the publication by the UNESCO UIS in 2022, global spending on R&D has reached a record high of almost US$ 1.7 trillion. About 10 countries account for 80% of spending.
Increasing focus on the development of innovative products is driving the researchers to conduct studies that are directly driving the market growth. Thus, the above factors are expected to drive the market growth.
High costs of virus filtration systems
The high costs of virus filtration systems are expected to hinder the market growth. The initial investment by the companies for the development of a drug or any biologics is associated with huge expenses. The high cost of virus filtration systems can reduce the adoption of these systems by medium and small-sized companies.
Market Segment Analysis
The global virus filtration market is segmented based on product, application, end-user and region.
Filtration systems segment is expected to dominate the market share
The filtration systems are expected to hold a significant portion of the market share. The increasing investments by pharmaceutical and biopharmaceutical companies necessitate advanced filtration systems in research. As the research and developmental activities increase, the need for virus filtration systems increases.
The increasing technological advancements in the filtration systems and innovation of advanced and efficient virus filtration systems drive the segment growth. These factors encourage the companies to adopt these systems. Thus, the above factors are expected to hold the segment in the dominant position.
Market Geographical Share
North America is expected to hold a significant position in the virus filtration market share
North America is expected to hold a significant position in the global virus filtration market during the forecast period due to the increasing production of biopharmaceutical and pharmaceutical production in the region, increasing technological advancements and the presence of a large number of market players.
The rise in the manufacturing of biologics and other biopharmaceutical products is considered to be the main factor for the market growth in the region. For instance, on October 1, 2024, Johnson & Johnson announced an investment of more than $2 billion to build a state-of-the-art biologics manufacturing facility in Wilson, North Carolina to expand the production of the company’s portfolio and pipeline of innovative biologics in support of Johnson & Johnson’s broader plan to advance more than 70 novel therapy and product expansion filings and launches by the end of the decade.
Additionally, on May 24, 2024, Eli Lilly and Company announced that it has more than doubled its investment in its Lebanon, Indiana, manufacturing site with a new $5.3 billion commitment, increasing the company's total investment in this site from $3.7 billion to $9 billion. This increases Lilly's capacity to manufacture active pharmaceutical ingredients (API) for various products. Thus, the above factors are expected to hold the region in a significant position in the market share.
Market Segmentation
By Product
- Consumables
- Kits and Reagents
- Others
- Instruments
- Filtration Systems
- Chromatography Systems
- Others
- Services
- Others
By Application
- Biological
- Vaccines and Therapeutics
- Blood and Blood Products
- Cellular and Gene Therapy Products
- Tissue and Tissue Products
- Other
- Medical Devices
- Water Purification
- Air Purification
- Other
By End-User
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic Research Institutes
- Other
By Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- South America
- Brazil
- Argentina
- Rest of South America
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Middle East and Africa
Market Competitive Landscape
The major global players in the market include Asahi Kasei Medical Co., Ltd., Merck KgaA, Sartorius Group, Agilitech, Cytiva, Stellar Scientific, and Cygnus Technologies among others.
Why Purchase the Report?
- To visualize the global virus filtration market segmentation based on product, application, end-user, and region as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of virus filtration market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as Excel consisting of key products of all the major players.
The global virus filtration market report would provide approximately 53 tables, 47 figures, and 176 pages.
Target Audience 2024
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
